Sclerosing hepatocellular carcinoma: Clinicopathologic features in seven patients from Taiwan and review of the literature

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1201-1205

  Yeh, Chun Nan ^a   Hung, Chien Fu ^a   Lee, Kam Fai ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Carcinoma; Hepatocellular

Indexed keywords

CALCIUM; PHOSPHATE;

ADULT; AGED; CALCIUM BLOOD LEVEL; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PHOSPHATE BLOOD LEVEL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLEROSING HEPATOCELLULAR CARCINOMA; SCLEROSIS; SYMPTOMATOLOGY; TAIWAN; TRANSARTERIAL CHEMOEMBOLIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN;

EID: 21944455940     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Department of Health, Executive Yuan, Republic of China. Annual report of cancer registration, 1997,
2. Gibson JB: Histological typing of tumors of the liver, biliary tract, and pancreas. Internal Histological classification of tumors. No. 20. WHO, Geneva, 1978.
3. Edmondson HA: Tumor of the liver and intrahepatic bile ducts. Section VII, Fascicle 20, Armed Forces Institute of Pathology, 1958.
4. Omata M, Peter RL, Tatter D: Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1981; 1:33-49.
5. Yamashita F, Iwao T, Torimura T, et al: Sclerosing hepatocellular carcinoma with hypercalcemia - A case report. The Kurume Med J 1992; 39:113-116.
6. Yamashita Y, Fan ZM, Yamamoto H, et al: Sclerosing hepatocellular carcinoma: Radiologic findings. Abdom Imaging 1993; 18:347-351.
7. Yoshida J, Takayama T, Yamamoto J, et al: Computed tomography of sclerosing hepatocellular carcinoma. Computerized Medical Imaging and Graphics 1992; 16(2):125-130.
8. Fry L: Pseudohyperparathyroidism of carcinoma of bronchus. Br Med J 1962; 1:301:302.
9. Yoshikawa J, Matsui O, Kadoya Y, et al: Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr 1995; 16:206-211.
10. Craig J, Peter R, Edmondson H, Omata M: Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 15; 46(2):372-379.
11. Poon RTP, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232 (1):10-24.
12. Tsai HP, Lee WC, Jeng LB, Chen MF: Clinicopathologic factors influencing long term survival after resection of hepatocellular carcinoma. Chang Gung Med J 2000; 23:529-535.